Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).

Ogawa R, Stachnik JM, Echizen H.

Clin Pharmacokinet. 2013 Mar;52(3):169-85. doi: 10.1007/s40262-012-0029-2. Review.

PMID:
23344981
2.

Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).

Ogawa R, Stachnik JM, Echizen H.

Clin Pharmacokinet. 2014 Dec;53(12):1083-114. doi: 10.1007/s40262-014-0189-3. Review.

PMID:
25248847
3.

Clinical pharmacokinetics in heart failure. An updated review.

Shammas FV, Dickstein K.

Clin Pharmacokinet. 1988 Aug;15(2):94-113. Review.

PMID:
3064953
4.

Pharmacokinetic drug interactions with ACE inhibitors.

Shionoiri H.

Clin Pharmacokinet. 1993 Jul;25(1):20-58. Review.

PMID:
8354016
5.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
6.

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.

Belz GG, Kirch W, Kleinbloesem CH.

Clin Pharmacokinet. 1988 Nov;15(5):295-318. Review.

PMID:
2849518
8.

Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

De Paepe P, Belpaire FM, Buylaert WA.

Clin Pharmacokinet. 2002;41(14):1135-51. Review.

PMID:
12405864
10.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
11.

Drug-patient interactions and their relevance in the treatment of heart failure.

Johnston D, Duffin D.

Am J Cardiol. 1992 Oct 8;70(10):109C-112C. Review.

PMID:
1329465
12.
13.

Digoxin remains useful in the management of chronic heart failure.

Dec GW.

Med Clin North Am. 2003 Mar;87(2):317-37. Review.

PMID:
12693728
14.

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.

PMID:
14727993
15.
16.
17.

Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

He YL.

Clin Pharmacokinet. 2012 Mar 1;51(3):147-62. doi: 10.2165/11598080-000000000-00000. Review.

PMID:
22339447
18.

Pathophysiology of chronic heart failure.

Francis GS.

Am J Med. 2001 May 7;110 Suppl 7A:37S-46S. Review.

PMID:
11334774
19.

Pharmacokinetic changes in patients with oedema.

Vrhovac B, Sarapa N, Bakran I, Huic M, Macolic-Sarinic V, Francetic I, Wolf-Coporda A, Plavsic F.

Clin Pharmacokinet. 1995 May;28(5):405-18. Review.

PMID:
7614778
20.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk